A.R.T. Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,295
Closed -$211K 1888
2017
Q4
$211K Buy
+1,295
New +$232K 0.01% 1146
2016
Q2
Sell
-26,625
Closed -$7.14M 1763
2016
Q1
$7.14M Buy
26,625
+19,300
+263% +$5.52M 0.32% 51
2015
Q4
$2.29M Buy
+7,325
New +$2.18M 0.11% 251
2015
Q2
Sell
-7,592
Closed -$2.26M 1823
2015
Q1
$2.26M Sell
7,592
-5,786
-43% -$1.65M 0.08% 349
2014
Q4
$3.44M Buy
+13,378
New +$3.34M 0.13% 212
2014
Q3
Sell
-63,923
Closed -$14.3M 1627
2014
Q2
$14.3M Buy
+63,923
New +$13.2M 0.74% 6
2013
Q4
Sell
-4,815
Closed -$693K 1626
2013
Q3
$693K Buy
+4,815
New +$641K 0.04% 637

Other funds holding AGN

A.R.T. Advisors's AGN Position: Q1 2018 in Review

A.R.T. Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,295 shares — an estimated $211K sold.

A.R.T. Advisors first reported a position in AGN in Q3 2013 and held it in 7 quarters. The position peaked at $14.3M in Q2 2014. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • A.R.T. Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 1,295 Allergan plc shares in Q1 2018, an estimated $211K.
  • A.R.T. Advisors first reported a position in Allergan plc in Q3 2013 and held it in 7 quarters.
  • A.R.T. Advisors's Allergan plc position peaked at $14.3M in Q2 2014.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on A.R.T. Advisors's 13F filing for Q1 2018, filed 15 May 2018.